Members.
- Published in:
- Biologist, 2017, v. 64, n. 3, p. 34
- Publication type:
- Article
Works matching DE "GW Pharmaceuticals PLC"
Results: 11
1
2
FLOWER POWER.
- Published in:
- Biologist, 2012, v. 59, n. 2, p. 15
- By:
- Publication type:
- Article
3
EU Financial accounts reports.
- Published in:
- Journal of Commercial Biotechnology, 2002, v. 8, n. 4, p. 355, doi. 10.5912/jcb453
- By:
- Publication type:
- Article
4
Movers & Shakers.
- Published in:
- Chemistry & Industry, 2012, v. 76, n. 11, p. 42, doi. 10.1002/cind.7611_12.x
- Publication type:
- Article
5
For MS relief you must break UK law.
- Published in:
- Chemistry & Industry, 2005, n. 4, p. 14
- By:
- Publication type:
- Article
6
Bayer signs deal to market GW's cannabis-based Sativex in UK.
- Published in:
- Chemistry & Industry, 2003, n. 11, p. 4
- Publication type:
- Article
7
Movers & Shakers.
- Published in:
- Chemistry & Industry, 2014, v. 78, n. 7, p. 46, doi. 10.1002/cind.787_16.x
- Publication type:
- Article
8
Cannabis-Based Medicines - GW Pharmaceuticals.
- Published in:
- Drugs in R&D, 2003, v. 4, n. 5, p. 306, doi. 10.2165/00126839-200304050-00005
- Publication type:
- Article
9
The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next.
- Published in:
- 2018
- By:
- Publication type:
- journal article
10
GW Announces UK Launch of World's First Prescription Cannabis Medicine.
- Published in:
- Operating Theatre Journal, 2010, n. 239, p. 8
- Publication type:
- Article
11
GW Announces UK Launch of World's First Prescription Cannabis Medicine.
- Published in:
- Operating Theatre Journal, 2010, n. 238, p. 8
- Publication type:
- Article